SCHEMBL3759447

SCHEMBL3759447

O=C(Cl)[C@@H]1C[C@@H]2CC[C@H]1C2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.55
L3MBTL1 Q9Y468 2/20 0.46
HSD11B1 P28845 1/20 0.44
P2RX7 Q99572 1/20 0.42
HPGD P15428 3/20 0.42
KCNQ3 O43525 1/20 0.42
KCNQ2 O43526 1/20 0.42
KCNQ4 P56696 1/20 0.42
KCNQ5 Q9NR82 1/20 0.42
MEN1 O00255 2/20 0.41
HTT P42858 2/20 0.41
KMT2A Q03164 2/20 0.41
GAA P10253 1/20 0.41
THRB P10828 1/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
KDM4E B2RXH2 1/20 0.40
HSD17B10 Q99714 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3759450 1.00 POLB (0.55) POLBL3MBTL1HSD11B1P2RX7HPGD
SCHEMBL5724602 0.87 POLB (0.42) POLBL3MBTL1HSD11B1P2RX7HPGD
SCHEMBL5415108 0.87 POLB (0.42) POLBL3MBTL1HSD11B1P2RX7HPGD
SCHEMBL5422425 0.87 POLB (0.42) POLBL3MBTL1HSD11B1P2RX7HPGD
SCHEMBL3079755 0.82 POLB (0.57) POLBL3MBTL1HSD11B1P2RX7HPGD
SCHEMBL21896031 0.82 POLB (0.57) POLBL3MBTL1HSD11B1P2RX7HPGD
SCHEMBL8742210 0.80 POLB (0.55) POLBL3MBTL1HSD11B1P2RX7HPGD
SCHEMBL8742209 0.80 POLB (0.55) POLBL3MBTL1HSD11B1P2RX7HPGD
SCHEMBL18629176 0.80 POLB (0.55) POLBL3MBTL1HSD11B1P2RX7HPGD
SCHEMBL744692 0.80 POLB (0.55) POLBL3MBTL1HSD11B1P2RX7HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962639-B2 Potassium channel modulators ABBVIE INC. (US) 2015-02-24 US disclosed
US-20100305109-A1 POTASSIUM CHANNEL MODULATORS ABBOTT LABORATORIES (US) 2010-12-02 US disclosed
US-20060094764-A1 Cyanothiophenes, their preparation and their use in pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094764-A1 Cyanothiophenes, their preparation and their use in pharmaceutical compositions GLRB, GPR6, GRM3 POLB 4077/4885L3MBTL1 4564/4885HSD11B1 1756/4885
US-20100305109-A1 POTASSIUM CHANNEL MODULATORS KCNQ1, KCNQ2, KCNJ2 POLB 4177/4885L3MBTL1 2666/4885HSD11B1 2467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.